Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
BETAMETHASONE DIPROPIONATE, SALICYLIC ACID
B & S Healthcare
D07XC01
BETAMETHASONE DIPROPIONATE, SALICYLIC ACID
0.05/3 Base %w/w
Ointment
Product subject to prescription which may be renewed (B)
Corticosteroids, potent, other combinations
Authorised
2007-07-13
PACKAGE LEAFLET: INFORMATION FOR THE USER DIPROSALIC ® 0.05%W/W + 3%W/W OINTMENT (betamethasone dipropionate/ salicylic acid) READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. The name of your medicine is Diprosalic ® 0.05%w/w + 3%w/w Ointment, but it will be referred to as Diprosalic throughout this leaflet. WHAT IS IN THIS LEAFLET: 1. What Diprosalic is and what it is used for 2. What you need to know before you use Diprosalic 3. How to use Diprosalic 4. Possible side effects 5. How to store Diprosalic 6. Contents of the pack and other information 1. WHAT DIPROSALIC IS AND WHAT IT IS USED FOR Diprosalic contains two active ingredients, betamethasone dipropionate and salicylic acid. Betamethasone dipropionate is one of a group of medicines called topical corticosteroids. It is classified as a “potent corticosteroid”. These medicines are put on the surface of the skin to reduce the redness and itchiness caused by certain skin problems. Salicylic acid softens the top layer of scales on the surface of the skin, which are caused by your skin problem. This allows the betamethasone dipropionate to reach the diseased skin underneath to help heal it. In adults and c Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Diprosalic 0.05% w/w + 3% w/w Ointment 2 QUALITATIVE AND QUANTITATIVE COMPOSITION The ointment contains 0.05% w/w betamethasone (as dipropionate) and 3% w/w salicylic acid. For full list of excipients, see section 6.1 3 PHARMACEUTICAL FORM Ointment _Product imported from France:_ Smooth, off-white ointment 4 CLINICAL PARTICULARS As per PA1328/028/002 5 PHARMACOLOGICAL PROPERTIES As per PA1328/028/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Liquid paraffin White soft paraffin. 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf-life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Do not store above 25°C. 6.5 NATURE AND CONTENTS OF CONTAINER Epoxy-lined aluminium tubes with plastic caps, containing 30g of product. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 10/04/2015_ _CRN 2158912_ _page number: 1_ 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER B & S Healthcare, Unit 4, Bradfield Road, Ruislip, Middlesex, HA4 0NU, United Kingdom 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA 1328/075/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of First Authorisation: 13 th July 2007 Date of Last Renewal: 13 th July 2012 10 DATE OF REVISION OF THE TEXT April 2015 HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Read the complete document